| Year |
Citation |
Score |
| 2024 |
Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li Y, Huang H, Hampton JM, Song J, Jayasekera J, Schechter C, Alagoz O, Stout NK, Trentham-Dietz A, Lee SJ, Huang X, et al. Analysis of Breast Cancer Mortality in the US-1975 to 2019. Jama. 331: 233-241. PMID 38227031 DOI: 10.1001/jama.2023.25881 |
0.478 |
|
| 2023 |
Mandelblatt JS, Schechter CB, Stout NK, Huang H, Stein S, Hunter Chapman C, Trentham-Dietz A, Jayasekera J, Gangnon RE, Hampton JM, Abraham L, O'Meara ES, Sheppard VB, Lee SJ. Population simulation modeling of disparities in US breast cancer mortality. Journal of the National Cancer Institute. Monographs. 2023: 178-187. PMID 37947337 DOI: 10.1093/jncimonographs/lgad023 |
0.45 |
|
| 2023 |
Kerlikowske K, Zhu W, Su YR, Sprague BL, Stout NK, Onega T, O'Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL. Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density. Journal of the National Cancer Institute. PMID 37897090 DOI: 10.1093/jnci/djad201 |
0.331 |
|
| 2023 |
Lee JM, Ichikawa LE, Wernli KJ, Bowles EJA, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Impact of Surveillance Mammography Intervals Less Than One Year on Performance Measures in Women With a Personal History of Breast Cancer. Korean Journal of Radiology. 24: 729-738. PMID 37500574 DOI: 10.3348/kjr.2022.1038 |
0.485 |
|
| 2023 |
Sprague BL, Ichikawa L, Eavey J, Lowry KP, Rauscher G, O'Meara ES, Miglioretti DL, Chen S, Lee JM, Stout NK, Mandelblatt JS, Alsheik N, Herschorn SD, Perry H, Weaver DL, et al. Breast cancer risk characteristics of women undergoing whole-breast ultrasound screening versus mammography alone. Cancer. PMID 37303202 DOI: 10.1002/cncr.34768 |
0.518 |
|
| 2022 |
Jayasekera J, Zhao A, Schechter C, Lowry K, Yeh JM, Schwartz MD, O'Neill S, Wernli KJ, Stout N, Mandelblatt J, Kurian AW, Isaacs C. Reassessing the Benefits and Harms of Risk-Reducing Medication Considering the Persistent Risk of Breast Cancer Mortality in Estrogen Receptor-Positive Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201342. PMID 36455167 DOI: 10.1200/JCO.22.01342 |
0.479 |
|
| 2022 |
Lowry KP, Callaway KA, Lee JM, Zhang F, Ross-Degnan D, Wharam JF, Kerlikowske K, Wernli KJ, Kurian AW, Henderson LM, Stout NK. Trends in Annual Surveillance Mammography Participation Among Breast Cancer Survivors From 2004 to 2016. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 379-386.e9. PMID 35390766 DOI: 10.6004/jnccn.2021.7081 |
0.492 |
|
| 2022 |
Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, et al. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis. Jama Oncology. PMID 35175286 DOI: 10.1001/jamaoncol.2021.6204 |
0.398 |
|
| 2021 |
Lowry KP, Bissell M, Miglioretti DL, Kerlikowske K, Alsheik N, Macarol T, Bowles EJA, Buist DSM, Tosteson ANA, Henderson L, Herschorn SD, Wernli KJ, Weaver DL, Stout NK, Sprague BL. Breast Biopsy Recommendations and Breast Cancers Diagnosed during the COVID-19 Pandemic. Radiology. 211808. PMID 34665032 DOI: 10.1148/radiol.2021211808 |
0.502 |
|
| 2021 |
Yeh JM, Lowry KP, Schechter CB, Diller LR, O'Brien G, Alagoz O, Armstrong GT, Hampton JM, Hudson MM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Nathan PC, ... ... Stout NK, et al. Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness. Journal of the National Cancer Institute. PMID 34324686 DOI: 10.1093/jnci/djab149 |
0.523 |
|
| 2021 |
Alagoz O, Lowry KP, Kurian AW, Mandelblatt JS, Ergun MA, Huang H, Lee SJ, Schechter CB, Tosteson ANA, Miglioretti DL, Trentham-Dietz A, Nyante SJ, Kerlikowske K, Sprague BL, Stout NK. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Journal of the National Cancer Institute. PMID 34258611 DOI: 10.1093/jnci/djab097 |
0.512 |
|
| 2021 |
Lee JM, Ichikawa LE, Wernli KJ, Bowles E, Specht JM, Kerlikowske K, Miglioretti DL, Lowry KP, Tosteson ANA, Stout NK, Houssami N, Onega T, Buist DSM. Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016. Radiology. 204581. PMID 34003059 DOI: 10.1148/radiol.2021204581 |
0.522 |
|
| 2021 |
Yeh JM, Stout NK, Chaudhry A, Christensen KD, Gooch M, McMahon PM, O'Brien G, Rehman N, Blout Zawatsky CL, Green RC, Lu CY, Rehm HL, Williams MS, Diller L, Wu AC. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33767345 DOI: 10.1038/s41436-021-01124-x |
0.319 |
|
| 2021 |
van Ravesteyn NT, Schechter CB, Hampton JM, Alagoz O, van den Broek JJ, Kerlikowske K, Mandelblatt JS, Miglioretti DL, Sprague BL, Stout NK, de Koning HJ, Trentham-Dietz A, Tosteson ANA. Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women. Journal of the National Cancer Institute. PMID 33515225 DOI: 10.1093/jnci/djaa218 |
0.538 |
|
| 2020 |
Wernli KJ, Callaway KA, Henderson LM, Kerlikowske K, Lee JM, Ross-Degnan D, Wallace JK, Wharam JF, Zhang F, Stout NK. Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016. Cancer. PMID 32985694 DOI: 10.1002/cncr.33140 |
0.467 |
|
| 2020 |
Yeh JM, Lowry KP, Schechter CB, Diller LR, Alagoz O, Armstrong GT, Hampton JM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Oeffinger KC, Trentham-Dietz A, Stout NK. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation: A Comparative Modeling Study. Annals of Internal Medicine. PMID 32628531 DOI: 10.7326/M19-3481 |
0.547 |
|
| 2019 |
Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, Conant EF, Hampton JM, Huang H, Kerlikowske K, Lee SJ, Miglioretti DL, Sprague BL, Tosteson ANA, Yaffe M, ... Stout NK, et al. Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States. Journal of the National Cancer Institute. PMID 31503283 DOI: 10.1093/Jnci/Djz184 |
0.574 |
|
| 2019 |
Conant EF, Barlow WE, Herschorn SD, Weaver DL, Beaber EF, Tosteson ANA, Haas JS, Lowry KP, Stout NK, Trentham-Dietz A, diFlorio-Alexander RM, Li CI, Schnall MD, Onega T, Sprague BL, et al. Association of Digital Breast Tomosynthesis vs Digital Mammography With Cancer Detection and Recall Rates by Age and Breast Density. Jama Oncology. PMID 30816931 DOI: 10.1001/Jamaoncol.2018.7078 |
0.564 |
|
| 2019 |
Lansdorp-Vogelaar I, Jagsi R, Jayasekera J, Stout NK, Mitchell SA, Feuer EJ. Evidence-based sizing of non-inferiority trials using decision models. Bmc Medical Research Methodology. 19: 3. PMID 30612554 DOI: 10.1186/S12874-018-0643-2 |
0.307 |
|
| 2019 |
Yeh J, Lowry KP, Schechter CB, Diller L, Alagoz O, Armstrong GT, Hampton JM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Oeffinger KC, Trentham-Dietz A, Stout NK. Clinical outcomes and cost-effectiveness of breast cancer screening for childhood cancer survivors treated with chest radiation: A comparative modeling study. Journal of Clinical Oncology. 37: 6525-6525. DOI: 10.1200/Jco.2019.37.15_Suppl.6525 |
0.625 |
|
| 2019 |
Yeh J, Stout NK, Chaudhry A, Gooch M, McMahon P, Christensen KD, Diller L, Wu AC. Population-based cancer predisposition testing as a component of newborn screening: A cost-effectiveness analysis. Journal of Clinical Oncology. 37: 10021-10021. DOI: 10.1200/Jco.2019.37.15_Suppl.10021 |
0.463 |
|
| 2019 |
Wernli K, Callaway K, Henderson L, Kerlikowske K, Lee J, Ross-Degnan D, Wallace J, Wharam J, Zhang F, Stout N. Trends in Breast MRI Use Among Women with BRCA Mutations: A National Claims Analysis 2006–2016 Cancer Epidemiology Biomarkers & Prevention. 28: 624.1-624. DOI: 10.1158/1055-9965.Epi-19-0079 |
0.514 |
|
| 2018 |
Caswell-Jin JL, Plevritis SK, Tian L, Cadham CJ, Xu C, Stout NK, Sledge GW, Mandelblatt JS, Kurian AW. Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review. Jnci Cancer Spectrum. 2: pky062. PMID 30627694 DOI: 10.1093/Jncics/Pky062 |
0.501 |
|
| 2018 |
Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK. The effect of mammography screening regimen on incidence-based breast cancer mortality. Journal of Medical Screening. 969141318780152. PMID 30049249 DOI: 10.1177/0969141318780152 |
0.586 |
|
| 2018 |
Stout NK, Cronin AM, Uno H, Ozanne EM, Hassett MJ, Frank ES, Greenberg CC, Punglia RS. Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Research and Treatment. PMID 29946862 DOI: 10.1007/S10549-018-4860-5 |
0.511 |
|
| 2018 |
Jayasekera J, Li Y, Schechter CB, Jagsi R, Song J, White J, Luta G, Chapman JW, Feuer EJ, Zellars RC, Stout N, Julian TB, Whelan T, Huang X, Shelley Hwang E, et al. Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer. Journal of the National Cancer Institute. PMID 29718314 DOI: 10.1093/Jnci/Djy059 |
0.506 |
|
| 2018 |
Alagoz O, Berry DA, de Koning HJ, Feuer EJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, Trentham-Dietz A, Mandelblatt JS. Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 3S-8S. PMID 29554472 DOI: 10.1177/0272989X17737507 |
0.584 |
|
| 2018 |
van den Broek JJ, van Ravesteyn NT, Mandelblatt JS, Cevik M, Schechter CB, Lee SJ, Huang H, Li Y, Munoz DF, Plevritis SK, de Koning HJ, Stout NK, van Ballegooijen M. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 112S-125S. PMID 29554471 DOI: 10.1177/0272989X17743244 |
0.601 |
|
| 2018 |
Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, Hampton JM, Stout NK, Trentham-Dietz A. The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 99S-111S. PMID 29554470 DOI: 10.1177/0272989X17711927 |
0.749 |
|
| 2018 |
van den Broek JJ, van Ravesteyn NT, Mandelblatt JS, Huang H, Ergun MA, Burnside ES, Xu C, Li Y, Alagoz O, Lee SJ, Stout NK, Song J, Trentham-Dietz A, Plevritis SK, Moss SM, et al. Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 140S-150S. PMID 29554468 DOI: 10.1177/0272989X17718168 |
0.582 |
|
| 2018 |
Gangnon RE, Stout NK, Alagoz O, Hampton JM, Sprague BL, Trentham-Dietz A. Contribution of Breast Cancer to Overall Mortality for US Women. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 24S-31S. PMID 29554467 DOI: 10.1177/0272989X17717981 |
0.555 |
|
| 2018 |
Mittmann N, Stout NK, Tosteson ANA, Trentham-Dietz A, Alagoz O, Yaffe MJ. Cost-effectiveness of mammography from a publicly funded health care system perspective. Cmaj Open. 6: E77-E86. PMID 29440151 DOI: 10.9778/cmajo.20170106 |
0.499 |
|
| 2018 |
Buist DSM, Abraham L, Lee CI, Lee JM, Lehman C, O'Meara ES, Stout NK, Henderson LM, Hill D, Wernli KJ, Haas JS, Tosteson ANA, Kerlikowske K, Onega T. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer. Jama Internal Medicine. PMID 29435556 DOI: 10.1001/Jamainternmed.2017.8549 |
0.591 |
|
| 2018 |
Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, Lee SJ, van den Broek JJ, Huang X, Schechter CB, Sprague BL, Song J, de Koning HJ, Trentham-Dietz A, van Ravesteyn NT, et al. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. Jama. 319: 154-164. PMID 29318276 DOI: 10.1001/Jama.2017.19130 |
0.579 |
|
| 2017 |
Burnside ES, Lee SJ, Bennette C, Near AM, Alagoz O, Huang H, van den Broek JJ, Kim JY, Ergun MA, van Ravesteyn NT, Stout NK, de Koning HJ, Mandelblatt JS. Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age. Mdm Policy & Practice. 2. PMID 29376135 |
0.469 |
|
| 2017 |
Hill DA, Haas JS, Wellman R, Hubbard RA, Lee CI, Alford-Teaster J, Wernli KJ, Henderson LM, Stout NK, Tosteson ANA, Kerlikowske K, Onega T. Utilization of breast cancer screening with magnetic resonance imaging in community practice. Journal of General Internal Medicine. PMID 29214373 DOI: 10.1007/S11606-017-4224-6 |
0.5 |
|
| 2017 |
Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. Breast Cancer Research and Treatment. PMID 29185118 DOI: 10.1007/S10549-017-4582-0 |
0.563 |
|
| 2017 |
Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, et al. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29150480 DOI: 10.1158/1055-9965.Epi-17-0378 |
0.515 |
|
| 2017 |
Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A. Emerging Trends in Family History of Breast Cancer and Associated Risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28986348 DOI: 10.1158/1055-9965.Epi-17-0531 |
0.548 |
|
| 2017 |
Loeb S, Stork B, Gold HT, Stout NK, Makarov DV, Weight C, Borgmann H. Tweet this: how advocacy for breast and prostate cancers stacks up on social media. Bju International. PMID 28471484 DOI: 10.1111/Bju.13908 |
0.423 |
|
| 2017 |
Wong SM, Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M. Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. Cancer. PMID 28221673 DOI: 10.1002/Cncr.30644 |
0.527 |
|
| 2016 |
Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, et al. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Annals of Internal Medicine. PMID 27548583 DOI: 10.7326/M16-0476 |
0.555 |
|
| 2016 |
Punglia RS, Cronin AM, Uno H, Stout NK, Ozanne EM, Greenberg CC, Frank ES, Schrag D. Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. Jama Oncology. PMID 27442038 DOI: 10.1001/Jamaoncol.2016.2164 |
0.445 |
|
| 2016 |
Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, et al. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Annals of Internal Medicine. PMID 26756606 DOI: 10.7326/M15-1536 |
0.554 |
|
| 2016 |
Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM. Cancer Models and Real-world Data: Better Together. Journal of the National Cancer Institute. 108. PMID 26538628 DOI: 10.1093/Jnci/Djv316 |
0.492 |
|
| 2016 |
Ayer T, Alagoz O, Stout NK, Burnside ES. Heterogeneity in women's adherence and its role in optimal breast cancer screening policies Management Science. 62: 1339-1362. DOI: 10.1287/Mnsc.2015.2180 |
0.524 |
|
| 2016 |
Wong SM, Stout NK, Punglia RS, Golshan M. Management of lobular carcinoma in situ: A decision analysis. Journal of Clinical Oncology. 34: 1048-1048. DOI: 10.1200/Jco.2016.34.15_Suppl.1048 |
0.472 |
|
| 2015 |
Haas JS, Hill DA, Wellman RD, Hubbard RA, Lee CI, Wernli KJ, Stout NK, Tosteson AN, Henderson LM, Alford-Teaster JA, Onega TL. Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status. Cancer. PMID 26709819 DOI: 10.1002/Cncr.29805 |
0.531 |
|
| 2015 |
Mittmann NM, Stout NK, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Yaffe MJ. Total cost-effectiveness of mammography screening strategies. Health Reports. 26: 16-25. PMID 26676235 |
0.495 |
|
| 2015 |
Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK. Clinical outcomes of modelling mammography screening strategies. Health Reports. 26: 9-15. PMID 26676234 |
0.421 |
|
| 2015 |
Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK. Modelling mammography screening for breast cancer in the Canadian context: Modification and testing of a microsimulation model. Health Reports. 26: 3-8. PMID 26676233 |
0.497 |
|
| 2015 |
Ozanne EM, Schneider KH, Soeteman D, Stout N, Schrag D, Fordis M, Punglia RS. onlineDeCISion.org: a web-based decision aid for DCIS treatment. Breast Cancer Research and Treatment. PMID 26475704 DOI: 10.1007/S10549-015-3605-Y |
0.336 |
|
| 2015 |
Cevik M, Ergun MA, Stout NK, Trentham-Dietz A, Craven M, Alagoz O. Using Active Learning for Speeding up Calibration in Simulation Models. Medical Decision Making : An International Journal of the Society For Medical Decision Making. PMID 26471190 DOI: 10.1177/0272989X15611359 |
0.335 |
|
| 2015 |
Weinmann S, Williams AE, Kamineni A, Buist DS, Masterson EE, Stout NK, Stark A, Ross TR, Owens CL, Field TS, Doubeni CA. Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007. Cancer. 121: 2976-83. PMID 25989253 DOI: 10.1002/Cncr.29445 |
0.388 |
|
| 2015 |
van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. Journal of the National Cancer Institute. 107. PMID 25948872 DOI: 10.1093/Jnci/Djv103 |
0.543 |
|
| 2015 |
Gangnon RE, Sprague BL, Stout NK, Alagoz O, Weedon-Fekjær H, Holford TR, Trentham-Dietz A. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 905-12. PMID 25787716 DOI: 10.1158/1055-9965.Epi-14-1286 |
0.597 |
|
| 2015 |
Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Annals of Internal Medicine. 162: 157-66. PMID 25486550 DOI: 10.7326/M14-0692 |
0.521 |
|
| 2015 |
Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD. Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts. Radiology. 274: 772-80. PMID 25350548 DOI: 10.1148/Radiol.14141237 |
0.527 |
|
| 2015 |
Ozanne EM, Stout NK, Schneider K, Soeteman D, Schrag D, Fordis M, Punglia RS. Abstract P2-10-01: onlineDeCISion.org : An interactive web-based clinical decision aid for DCIS treatment Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-10-01 |
0.375 |
|
| 2014 |
Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, Burnside ES, Chang Y, Chisholm G, de Koning HJ, Ali Ergun M, Heijnsdijk EA, Huang H, Stout NK, et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. Journal of the National Cancer Institute. 106. PMID 25255803 DOI: 10.1093/Jnci/Dju289 |
0.532 |
|
| 2014 |
Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. Journal of the National Cancer Institute. 106: dju092. PMID 24872543 DOI: 10.1093/Jnci/Dju092 |
0.509 |
|
| 2014 |
Wang AT, Fan J, Van Houten HK, Tilburt JC, Stout NK, Montori VM, Shah ND. Impact of the 2009 US Preventive Services Task Force guidelines on screening mammography rates on women in their 40s. Plos One. 9: e91399. PMID 24618830 DOI: 10.1371/Journal.Pone.0091399 |
0.467 |
|
| 2014 |
Stout NK, Nekhlyudov L, Li L, Malin ES, Ross-Degnan D, Buist DS, Rosenberg MA, Alfisher M, Fletcher SW. Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011. Jama Internal Medicine. 174: 114-21. PMID 24247482 DOI: 10.1001/Jamainternmed.2013.11958 |
0.49 |
|
| 2014 |
Mittmann N, Stout N, Tosteson A, Yaffe M. Cost Effectiveness of Different Digital Mammography Screening Scenarios for Breast Cancer in the Canadian Context Value in Health. 17: A89. DOI: 10.1016/J.Jval.2014.03.516 |
0.586 |
|
| 2013 |
Soeteman DI, Stout NK, Ozanne EM, Greenberg C, Hassett MJ, Schrag D, Punglia RS. Modeling the effectiveness of initial management strategies for ductal carcinoma in situ. Journal of the National Cancer Institute. 105: 774-81. PMID 23644480 DOI: 10.1093/Jnci/Djt096 |
0.355 |
|
| 2013 |
Chubak J, Rutter CM, Kamineni A, Johnson EA, Stout NK, Weiss NS, Doria-Rose VP, Doubeni CA, Buist DS. Measurement in comparative effectiveness research. American Journal of Preventive Medicine. 44: 513-9. PMID 23597816 DOI: 10.1016/J.Amepre.2013.01.006 |
0.303 |
|
| 2013 |
Batina NG, Trentham-Dietz A, Gangnon RE, Sprague BL, Rosenberg MA, Stout NK, Fryback DG, Alagoz O. Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Research and Treatment. 138: 519-28. PMID 23417335 DOI: 10.1007/S10549-013-2435-Z |
0.709 |
|
| 2012 |
van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Annals of Internal Medicine. 156: 609-17. PMID 22547470 DOI: 10.1097/01.Ogx.0000418532.21029.Ea |
0.569 |
|
| 2012 |
Buist D, Tuzzio L, Greenlee R, Field T, Williams A, Weinmann S, Stout N, Kamineni A, Doubeni C. PS1-33: Cancer Screening Guideline Development, Implementation and Dissemination: Connection Points for Researchers and Health Care Delivery Systems for Comparative Effectiveness Research Clinical Medicine & Research. 10: 157-157. DOI: 10.3121/Cmr.2012.1100.Ps1-33 |
0.418 |
|
| 2012 |
Weinmann S, Masterson E, Gold H, Kamineni A, Williams A, Stout N, Stark A, Field T, Richert-Boe K. PS1-25: Cervical Cancer Testing and Follow-up in Four Managed Care Plans, 1998-2007 Clinical Medicine & Research. 10: 150-151. DOI: 10.3121/Cmr.2012.1100.Ps1-25 |
0.415 |
|
| 2012 |
Ayer T, Alagoz O, Stout NK. OR forum-A POMDP approach to personalize mammography screening decisions Operations Research. 60: 1019-1034. DOI: 10.1287/Opre.1110.1019 |
0.568 |
|
| 2012 |
Van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DSM, Huang H, Heijnsdijk EAM, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: A comparative modeling study of risk: Editorial Comment Obstetrical and Gynecological Survey. 67: 481-482. DOI: 10.1097/01.Ogx.0000418532.21029.Ea |
0.395 |
|
| 2012 |
Ravesteyn NTv, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DSM, Huang H, Heijnsdijk EAM, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, Koning HJd. What level of risk tips the balance of benefits and harms to favor screening mammography starting at age 40 Annals of Internal Medicine. 156: 609. DOI: 10.1059/0003-4819-156-9-201205010-00002 |
0.394 |
|
| 2011 |
Mandelblatt JS, Cronin KA, Berry DA, Chang Y, de Koning HJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, van Ravesteyn NT, Zelen M, Feuer EJ. Modeling the impact of population screening on breast cancer mortality in the United States. Breast (Edinburgh, Scotland). 20: S75-81. PMID 22015298 DOI: 10.1016/S0960-9776(11)70299-5 |
0.535 |
|
| 2011 |
Mandelblatt JS, Stout N, Trentham-Dietz A. To screen or not to screen women in their 40s for breast cancer: is personalized risk-based screening the answer? Annals of Internal Medicine. 155: 58-60. PMID 21727294 DOI: 10.7326/0003-4819-155-1-201107050-00008 |
0.558 |
|
| 2011 |
Stout NK, Nekhlyudov L. Early uptake of breast magnetic resonance imaging in a community-based medical practice, 2000-2004. Journal of Women's Health (2002). 20: 631-4. PMID 21413899 DOI: 10.1089/Jwh.2010.2159 |
0.446 |
|
| 2011 |
Trentham-Dietz A, Sprague B, Alagoz O, Reaidi P, Rosenberg M, Gangnon R, Stout N. The Impact of Detection and Treatment of Carcinoma In Situ on Breast Cancer Mortality Cancer Epidemiology Biomarkers & Prevention. 20: 720-720. DOI: 10.1158/1055-9965.Epi-11-0096 |
0.608 |
|
| 2011 |
Mandelblatt J, Cronin K, Berry D, Feuer E, de Koning H, Lee S, Plevritis S, Schechter C, Stout N, van Ravesteyn N, Zelen M. S20 Changing the guidelines for breast cancer screening: modeling mammography benefits and harms The Breast. 20: S7-S8. DOI: 10.1016/S0960-9776(11)70023-6 |
0.604 |
|
| 2010 |
Goldhaber-Fiebert JD, Stout NK, Goldie SJ. Empirically evaluating decision-analytic models. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 13: 667-74. PMID 20230547 DOI: 10.1111/J.1524-4733.2010.00698.X |
0.307 |
|
| 2010 |
Gee AM, Pfalzer L, Stout N, Levy E, McGarvey C, Springer B, Soballe P, Gerber L. Abstract P1-10-06: Racial Disparities in Physical and Functional Domains in Women with Early Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P1-10-06 |
0.435 |
|
| 2009 |
Gerber NL, Diao G, Stout N, Soballe P, McGarvey C, Pfalzer L, Springer B, Shieh C. Correlates of clinically significant fatigue in women with newly diagnosed breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e20517. PMID 27960913 DOI: 10.1200/Jco.2009.27.15_Suppl.E20517 |
0.524 |
|
| 2009 |
Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 27: 533-45. PMID 19663525 DOI: 10.2165/11314830-000000000-00000 |
0.387 |
|
| 2009 |
Mandelblatt JS, Cronin KA, Bailey S, Berry DA, Koning HJd, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, et al. Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms Annals of Internal Medicine. 151: 738-747. DOI: 10.1059/0003-4819-151-10-200911170-00010 |
0.596 |
|
| 2008 |
Stout NK, Goldie SJ. Keeping the noise down: common random numbers for disease simulation modeling. Health Care Management Science. 11: 399-406. PMID 18998599 DOI: 10.1007/S10729-008-9067-6 |
0.389 |
|
| 2008 |
Stout NK, Goldhaber-Fiebert JD, Ortendahl JD, Goldie SJ. Trade-offs in cervical cancer prevention: balancing benefits and risks. Archives of Internal Medicine. 168: 1881-9. PMID 18809815 DOI: 10.1001/Archinte.168.17.1881 |
0.405 |
|
| 2008 |
Tosteson AN, Stout NK, Fryback DG, Acharyya S, Herman BA, Hannah LG, Pisano ED. Cost-effectiveness of digital mammography breast cancer screening. Annals of Internal Medicine. 148: 1-10. PMID 18166758 DOI: 10.7326/0003-4819-148-1-200801010-00002 |
0.7 |
|
| 2007 |
Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA. Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Population Health Metrics. 5: 11. PMID 17967185 DOI: 10.1186/1478-7954-5-11 |
0.392 |
|
| 2007 |
Kim JJ, Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Multiparameter calibration of a natural history model of cervical cancer. American Journal of Epidemiology. 166: 137-50. PMID 17526866 DOI: 10.1093/Aje/Kwm086 |
0.369 |
|
| 2006 |
Fryback DG, Stout NK, Rosenberg MA, Trentham-Dietz A, Kuruchittham V, Remington PL. The Wisconsin Breast Cancer Epidemiology Simulation Model. Journal of the National Cancer Institute. Monographs. 37-47. PMID 17032893 DOI: 10.1093/Jncimonographs/Lgj007 |
0.728 |
|
| 2006 |
Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. Journal of the National Cancer Institute. 98: 774-82. PMID 16757702 DOI: 10.1093/Jnci/Djj210 |
0.621 |
|
| 2001 |
Fryback DG, Stout NK, Rosenberg MA. An elementary introduction to Bayesian computing using WinBUGS. International Journal of Technology Assessment in Health Care. 17: 98-113. PMID 11329849 DOI: 10.1017/S0266462301104095 |
0.527 |
|
| Show low-probability matches. |